A systematic review was performed to evaluate the biological effects of Cannabidiol (CBD),
one of the major components of Cannabis Sativa, on normal human healthy cell populations …

This systematic review examine the biological effects of CBD, a major component of
therapeutic Cannabis, on human pathological and cancer cell populations of integumentary …

Cannabidiol (CBD), a major nonpsychotropic constituent of Cannabis, has multiple
pharmacological actions, including anxiolytic, antipsychotic, antiemetic and anti …

Considering data from in vitro and in vivo studies, cannabidiol (CBD) seems to be a
promising candidate for the treatment of both somatic and psychiatric disorders. The aim of …

Introduction: Cannabidiol (CBD) can be isolated from Cannabis sativa L. or synthetically
produced. The aim of this study was to compare the in vitro effects of purified natural and …

Cannabidiol (CBD), a non-psychoactive compound derived from Cannabis Sativa, has
garnered increasing attention for its diverse therapeutic potential. This comprehensive …

Cannabidiol (CBD), a major phytocannabinoid constituent of cannabis, is attracting growing
attention in medicine for its anxiolytic, antipsychotic, antiemetic and anti-inflammatory …

The literature provides scientific evidence for the beneficial effects of cannabidiol (CBD), and
these effects extend beyond epilepsy treatment (eg, Lennox–Gastaut and Dravet …

The pharmacological importance of cannabidiol (CBD) has been in study for several years.
CBD is the major nonpsychoactive constituent of plant Cannabis sativa and its …

Introduction: This literature survey aims to extend the comprehensive survey performed by
Bergamaschi et al. in 2011 on cannabidiol (CBD) safety and side effects. Apart from …